{"nct_id":"NCT02497469","title":"An Efficacy and Safety Study of Vedolizumab Intravenous (IV) Compared to Adalimumab Subcutaneous (SC) in Participants With Ulcerative Colitis","status":"COMPLETED","status_verified_date":"2020-01","start_date":"2015-06-29","start_date_type":"ACTUAL","primary_completion_date":"2018-09-26","primary_completion_date_type":"ACTUAL","completion_date":"2019-01-18","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["TAK"]}